Mirum Pharmaceuticals

Forecast & Rating14 analysts currently cover Mirum Pharmaceuticals, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $145.79, about 66.5% upside from the current price of $87.54. Price targets range from $118.00 to $195.00 — a wide spread, showing clear disagreement over just how much Mirum Pharmaceuticals can rise. Historically, about 29.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Mirum Pharmaceuticals closely still see room for the stock to rise. Data as of Sep 29, 2026; for reference only and not investment advice.